Literature DB >> 7261639

Critical care problems in neonates. Colloid osmotic pressure in healthy and sick neonates.

R Bhat, S Javed, L Malalis, D Vidyasagar.   

Abstract

Clinical usefulness of colloid osmotic pressure (COP) measurements in adults has been well established. However, data in healthy and sick neonates are sparse. The present study established the COP changes in healthy term and preterm infants and in critically ill neonates. COP in healthy term (16.9 +/- 1.9 mm Hg) and preterm (15.4 +/- 1.3) infants was significantly lower than adults (21.6 +/- 3.6). Even in sick neonates, COP correlated with gestational age (n = 78, r = 0.63, p less than 0.001 , birth weight (r = 0.58, p less than 0.001) and total protein (n = 71, r = 0.58, p less than 0.001). Critically ill preterm infants with hyaline membrane disease had the lowest COP (11.5 +/- 1.2). Administration of 10% albumin failed to increase the COP significantly. In critically ill preterm infants who survived, the COP increased during the first postnatal week, whereas in nonsurvivors COP decreased significantly to less than 10 mm Hg.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7261639     DOI: 10.1097/00003246-198108000-00001

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  3 in total

1.  Plasma colloid osmotic pressure in healthy infants.

Authors:  J B Sussmane; M de Soto; D Torbati
Journal:  Crit Care       Date:  2001-08-09       Impact factor: 9.097

2.  Interstitial fluid colloid osmotic pressure in healthy children.

Authors:  Hans Jørgen Timm Guthe; Marianne Indrebø; Torbjørn Nedrebø; Gunnar Norgård; Helge Wiig; Ansgar Berg
Journal:  PLoS One       Date:  2015-04-08       Impact factor: 3.240

3.  Transcapillary fluid flux and inflammatory response during neonatal therapeutic hypothermia: an open, longitudinal, observational study.

Authors:  Hans Jørgen Timm Guthe; Torbjørn Nedrebø; Jan Kristian Damås; Helge Wiig; Ansgar Berg
Journal:  BMC Pediatr       Date:  2018-02-23       Impact factor: 2.125

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.